Creative Touch Permanent Makeup and Aesthetics

Ceramide NP is the most reliably hydration-correlated ceramide subtype in the human stratum corneum, with direct, measurable links to both transepidermal water loss and skin capacitance across healthy, diseased, and hormonally disrupted skin. Its structure pairs a non-hydroxy fatty acid chain with a phytosphingosine backbone, making it chemically similar to Ceramide AP but without the alpha-hydroxy group that distinguishes that subtype. NP is the ceramide most commonly used in topical barrier repair formulations, and the one most people mean when a product simply says “ceramide” on its label.

What NP contributes structurally is participation in the crystalline lateral packing of the stratum corneum lipid matrix, primarily within the short periodicity phase alongside Ceramide AP and the other phytosphingosine subtypes. Research using model membranes with physiological ternary lipid mixtures, specifically Cer[NP], cholesterol, and free fatty acid, has confirmed that this combination generates orthorhombic lateral packing in the lipid structure, the tightest lipid arrangement associated with effective moisture retention. A formulation based on this ternary mixture at clinically validated concentrations reduced TEWL by 38–45% within 14 days of twice-daily application in model membrane studies. This positions NP not just as the best-studied ceramide subtype but as the most formulation-tested one, which is practically important when evaluating product claims.

NP as a Hydration Biomarker

Ceramide NP’s role as a direct correlate of skin hydration status is well established in primary research. In healthy skin, NP levels in the stratum corneum show consistent positive correlation with capacitance, the standard measure of hydration, and negative correlation with transepidermal water loss. Critically, this relationship holds in both healthy subjects and those with compromised barriers. In dry winter skin, NP levels correlated not only with conductance but with the clinician-assessed visual dryness grade. ^[2]

In atopic dermatitis and psoriasis, Ceramide NP is among the subtypes most significantly reduced, alongside Cer[NH]. Its depletion shows the strongest negative correlation with TEWL among the ceramide subtypes studied, and the NP:NS ratio has been proposed as a clinical biomarker for barrier impairment severity. Research using model membranes replicating the altered NS:NP ratios found in atopic skin found that a higher NS:NP ratio (more sphingosine ceramide relative to phytosphingosine ceramide) measurably increased TEWL, even without other changes to lipid composition. NP is, in this sense, not simply the most abundant ceramide but the one whose relative proportion most reliably predicts how well the barrier performs. ^[1]

This also clarifies why the NP:NS ratio matters in multi-ceramide formulations. A product built on Ceramide NP alone, whilst common and beneficial, does not address lamellar phase balance. A physiological multi-ceramide approach that includes appropriate NP, NS, and acylceramide ratios more accurately mirrors what the skin needs to restore both structural arrangement and hydration capacity.

Hormonal Changes and NP Production

Post-menopausal skin consistently shows reduced overall ceramide content alongside a shortening of average ceramide chain length, changes not evident in women taking HRT. The mechanism appears to lie upstream of individual ceramide synthesis, most likely at the level of serine palmitoyltransferase (SPT), the rate-limiting enzyme that initiates de novo ceramide biosynthesis. Because SPT produces the sphingoid base shared by all ceramide subtypes, its suppression reduces NP alongside every other subclass. Additionally, elevated post-menopausal sphingomyelin levels suggest that the hydrolysis pathway converting sphingomyelin to ceramide is also less active, compounding the shortfall. ^[3]

The chain length finding is specifically relevant to NP’s function. Shorter ceramide chains disrupt the tight, crystalline lateral packing that defines effective barrier organisation, increasing permeability even when ceramide abundance might appear adequate on total content measures. This helps explain why perimenopausal clients often experience persistent dryness despite consistently applying ceramide products: if the ceramide chains are shorter than physiological, the structural arrangement they support is less tight regardless of quantity applied topically.

At Creative Touch, this informs how we discuss barrier support for clients navigating hormonal transitions. The goal of topical NP-containing formulations during this life stage is not to replace everything oestrogen was doing but to compensate at the structural level for what declining synthesis produces. A formulation combining NP with cholesterol and free fatty acids in physiological ratios, rather than ceramide content alone, is what the evidence supports. This is why we always direct clients toward products that list specific ceramide types and include the full lipid triad, rather than relying on ceramide percentage claims that tell only part of the story.